FDA Approves Novel Schizophrenia Drug

]]>(MedPage Today) -- Lumateperone (Caplyta) was approved for treating schizophrenia in adults, drugmaker Intra-Cellular Therapeutics announced on Monday.The drug's anticipated approval comes after the FDA cancelled a scheduled advisory panel meeting...